<DOC>
	<DOCNO>NCT01322438</DOCNO>
	<brief_summary>The purpose study see give rifampin , market antibiotic , change body absorbs distribute BAY73-4506 .</brief_summary>
	<brief_title>Effect Rifampin Pharmacokinetics BAY73-4506</brief_title>
	<detailed_description />
	<mesh_term>Rifampin</mesh_term>
	<criteria>Healthy male subject Age : 18 45 year ( inclusive ) first screen examination / visit Body mass index ( BMI ) : 18 32 kg/mÂ² ( inclusive ) Ability understand follow studyrelated instruction Subjects enrol study must use adequate barrier birth control measure prior , course study , 3 month last administration regorafenib . An adequate contraception include use condom vasectomy . In addition , adequate birth control measure subject 's partner require , hormonal contraception implant combine oral contraceptive , certain intrauterine device , bilateral tubal ligation , hysterectomy . Clinically significant disease condition Recent serious infection</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>healthy volunteer</keyword>
	<keyword>rifampin</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>single dose</keyword>
</DOC>